Salubris (信立泰) A+H Pre-IPO: 1H26 Results Update
Salubris is seeking an A+H listing. In this note we update the company's fundamentals and business development since our last coverage.
36 Views
Primer: Livzon Pharmaceutical Group (1513 HK) - May 2026
Livzon is a diversified pharmaceutical company with a strong foothold in key therapeutic areas like gastroenterology and reproductive health,...
128 Views
A-H Premium Weekly (Oct 9th): Innocare, Ganfenglithium, China East Air, Yofc
We analyzed A-H premium changes in the past week and highlight A-H premium changes for Innocare, Ganfenglithium, China East Air, Yofc.
87 Views
HK Connect Flows Weekly (Sep 24th): Knowledge Atlas, Bidu, AIA, Chinagoldintl, Hua Hong Semi, CNOOC
We analyzed southbound Hong Kong connect flows in the past week and highlighted flows for Knowledge Atlas, Bidu, AIA, Chinagoldintl, Hua Hong Semi,...
106 Views
APAC Healthcare Weekly (October 19) – Hansoh, Leads Biolabs, Chugai, SanBio, Celltrion, Samsung Bio
Hansoh and Leads Biolabs bag global outlicensing deals. Chugai’s partner Lilly announced positive P3 result for orforglipron. Celltrion launched...
1k Views